JOHN CARTWRIGHT: Open Payments
NPI 1841760733 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 104 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $478 · 2025 $2,156
Food & beverage: $2,135Education: $21
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $395 |
| Medtronic, Inc. | 3 | $181 |
| Amneal Pharmaceuticals LLC | 10 | $178 |
| Dexcom, Inc. | 9 | $150 |
| Xeris Pharmaceuticals, Inc. | 8 | $145 |
| Corcept Therapeutics | 13 | $139 |
| Antares Pharma, Inc. | 7 | $132 |
| Madrigal Pharmaceuticals | 1 | $104 |
| Sequel Med Tech, LLC | 1 | $73 |
| Tandem Diabetes Care, Inc. | 6 | $69 |
Products named: Wegovy, MINIMED 780G, UNITHROID, Korlym, XYOSTED, REZDIFFRA, Ozempic, RECORLEV.
Industry payments across PA — which companies pay providers there.
